Alpha 2.0
Login Register
» Journals » Acta Med Austriaca Suppl

Acta Medica Austriaca. Supplement

Acta Medica Austriaca. Supplement is a scientific journal, published since 1974 in German. The journal's country of origin is Austria and its primary focus area is general medicine.
Details
Abbr. Acta Med Austriaca Suppl
Start 1974
End 2004
Frequency Irregular
p-ISSN 0303-8181
Country Austria
Language German
Specialty General Medicine
Recent Articles
1.
2004 Annual Spring Meeting of the Austrian Society of Hematology and Oncology. 15-17 April 2004, Vienna, Austria. Abstracts
Acta Med Austriaca Suppl . 2004 Jun; 63:1-31. PMID: 15202438
No abstract available.
2.
[Abstracts of the 31st Annual Meeting of the Austrian Society of Diabetes. 27-29 November 2003]
Acta Med Austriaca Suppl . 2004 Feb; 62:1-17. PMID: 14753186
No abstract available.
3.
Abstracts of the Annual Spring Meeting of the Austrian Society of Hematology and Oncology. Dornbirn, 27-29 March 2003
Acta Med Austriaca Suppl . 2003 Jun; 61:1-32. PMID: 12820637
No abstract available.
4.
[30th Annual Meeting of the Austrian Society of Diabetes. 28-30 November 2002, Graz. Abstracts]
Acta Med Austriaca Suppl . 2003 Jan; 60:1-24. PMID: 12530387
No abstract available.
5.
Abstracts of the 4th Middle European Congress of Internal Medicine. July 1-3, 1999
Acta Med Austriaca Suppl . 2003 Jan; 49:1-35. PMID: 12508808
No abstract available.
6.
1999 Spring Meeting of the Austrian Society of Hematology and Oncology. Abstracts
Acta Med Austriaca Suppl . 2003 Jan; 48:1-24. PMID: 12508807
No abstract available.
7.
Annual spring meeting of the Austrian Society of Hematology and Oncology. 23-25 April 1998, Baden, Vienna. Abstracts
Acta Med Austriaca Suppl . 2003 Jan; 46:1-44. PMID: 12508805
No abstract available.
8.
[Treatment of residual disease in chronic myeloid leukemia with STI-571 (Glivec)]
Geissler K, Agis H, Sagaster V
Acta Med Austriaca Suppl . 2003 Jan; 59:66-8. PMID: 12506764
Cytoreductive therapy can ameliorate symptoms in chronic myeloid leukemia (CML) but only treatment beyond hematologic remission aiming to affect the leukemic clone can improve prognosis. Up to now bone marrow...
9.
[Cell proliferation and cell death in disseminated tumor cells]
Mehes G, Ladenstein R, Gadner H, Ambros P
Acta Med Austriaca Suppl . 2003 Jan; 59:62-4. PMID: 12506763
The occurrence of occult metastases of solid tumors at initial diagnosis or during follow-up is of crucial therapeutical importance. The sensitive detection of such cells in hematological samples depends on...
10.
[Detection, quantification and characterization of disseminated tumor cells]
Ambros P, Mehes G, Ambros I, Luegmayr A, Ladenstein R, Gadner H
Acta Med Austriaca Suppl . 2003 Jan; 59:58-61. PMID: 12506762
There are different reasons why the detection of disseminated tumor cells (DTCs) in the hematopoetic system is important. On the one hand the detection of disseminated tumor cells can provide...